These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24742172)

  • 41. Long-acting reversible contraception: a review in special populations.
    Prescott GM; Matthews CM
    Pharmacotherapy; 2014 Jan; 34(1):46-59. PubMed ID: 24130075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Awareness of long-acting reversible contraception among teens and young adults.
    Teal SB; Romer SE
    J Adolesc Health; 2013 Apr; 52(4 Suppl):S35-9. PubMed ID: 23535055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increasing LARC utilization: any woman, any place, any time.
    Hathaway M; Torres L; Vollett-Krech J; Wohltjen H
    Clin Obstet Gynecol; 2014 Dec; 57(4):718-30. PubMed ID: 25314089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Young women's attitudes towards, and experiences of, long-acting reversible contraceptives.
    Bracken J; Graham CA
    Eur J Contracept Reprod Health Care; 2014 Aug; 19(4):276-84. PubMed ID: 24882426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urban-rural differences in attitudes and practices toward long-acting reversible contraceptives among family planning providers in Texas.
    Vaaler ML; Kalanges LK; Fonseca VP; Castrucci BC
    Womens Health Issues; 2012 Mar; 22(2):e157-62. PubMed ID: 22265180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IUD use in France: women's and physician's perspectives.
    Moreau C; Bohet A; Hassoun D; Ringa V; Bajos N;
    Contraception; 2014 Jan; 89(1):9-16. PubMed ID: 24239330
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current challenges in contraception in adolescents and young women.
    Cornet A
    Curr Opin Obstet Gynecol; 2013 Mar; 25 Suppl 1():S1-10. PubMed ID: 23370330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Provision of contraception: a survey among primary care physicians in Finland.
    Sannisto T; Kosunen E
    Acta Obstet Gynecol Scand; 2010 May; 89(5):636-45. PubMed ID: 20423277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Accessibility of long-acting reversible contraceptives (LARCs) in Federally Qualified Health Centers (FQHCs).
    Beeson T; Wood S; Bruen B; Goldberg DG; Mead H; Rosenbaum S
    Contraception; 2014 Feb; 89(2):91-6. PubMed ID: 24210278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uptake and adherence to long-acting reversible contraception post-abortion.
    Rose SB; Lawton BA; Brown SA
    Contraception; 2010 Oct; 82(4):345-53. PubMed ID: 20851228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Promotion of Long-Acting Reversible Contraception Among Adolescents and Young Adults.
    Santibenchakul S; Tschann M; Carlson ADP; L Hurwitz E; Salcedo J
    J Midwifery Womens Health; 2019 Mar; 64(2):194-200. PubMed ID: 30570219
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Teen pregnancy prevention on a LARC: an update on long-acting reversible contraception for the primary care provider.
    Dodson NA; Gray SH; Burke PJ
    Curr Opin Pediatr; 2012 Aug; 24(4):439-45. PubMed ID: 22732635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics of users of intrauterine devices and other reversible contraceptive methods in the United States.
    Xu X; Macaluso M; Frost J; Anderson JE; Curtis K; Grosse SD
    Fertil Steril; 2011 Nov; 96(5):1138-44. PubMed ID: 21917255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LARCs as first-line contraception - What can general practitioners advise young women?
    Temple-Smith M; Sanci L
    Aust Fam Physician; 2017 Oct; 46(10):710-715. PubMed ID: 29036768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Knowledge and factors determining choice of contraception among Singaporean women.
    Gosavi A; Ma Y; Wong H; Singh K
    Singapore Med J; 2016 Nov; 57(11):610-615. PubMed ID: 26762287
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Satisfaction, early removal, and side effects associated with long-acting reversible contraception.
    Dickerson LM; Diaz VA; Jordon J; Davis E; Chirina S; Goddard JA; Carr KB; Carek PJ
    Fam Med; 2013; 45(10):701-7. PubMed ID: 24347187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Obstetrician-gynecologists and contraception: practice and opinions about the use of IUDs in nulliparous women, adolescents and other patient populations.
    Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J
    Contraception; 2014 Jun; 89(6):572-7. PubMed ID: 24679477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-acting reversible contraception: Findings from the Understanding Fertility Management in Contemporary Australia survey.
    Holton S; Rowe H; Kirkman M; Jordan L; McNamee K; Bayly C; McBain J; Sinnott V; Fisher J
    Eur J Contracept Reprod Health Care; 2016; 21(2):116-31. PubMed ID: 26043118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A multicenter survey of contraceptive knowledge among adolescents in North America.
    Sokkary N; Mansouri R; Yoost J; Focseneanu M; Dumont T; Nathwani M; Allen L; Hertweck SP; Dietrich JE
    J Pediatr Adolesc Gynecol; 2013 Oct; 26(5):274-6. PubMed ID: 23849092
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and associations of prescribing of long-acting reversible contraception by general practitioner registrars: a secondary analysis of ReCEnT data.
    Turner R; Tapley A; Sweeney S; Davey A; Holliday E; van Driel M; Henderson K; Ball J; Morgan S; Spike N; FitzGerald K; Magin P
    BMJ Sex Reprod Health; 2020 Jul; 46(3):218-225. PubMed ID: 31964777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.